Pretransplant Coagulopathy and In‐hospital Outcomes Among Heart Transplant Recipients: A Propensity‐Matched Nationwide Inpatient Sample Study

Abstract

Background:The prevalence and contemporary trends of pre-heart transplantation (HT) coagulopathy and associated clinical outcomes have not been studied from a national database. Hypothesis: Pre-HT coagulopathy is associated with increased in-hospital mortality. Methods: Among 2454 adult HT recipients from the 2003 to 2010 Nationwide Inpatient Sample databases, 707 (29%) had pre-HT coagulopathy (defined as a comorbidity variable, based on International Classification of Diseases, Ninthe Revision, Clinical Modification and Diagnosis Related Group codes). We used propensity scores for coagulopathy to assemble a matched cohort of 664 pairs of patients with and without coagulopathy balanced in 54 baseline characteristics. Results: The prevalence of pre-HT coagulopathy increased from 17% in 2003 to 44% in 2010 (P for trend <0.001). In-hospital mortality occurred in 8.6% and 4.7% of matched HT recipients with and without coagulopathy, respectively (hazard ratio: 1.81; 95% confidence interval [CI]: 1.17-2.80; P = 0.008). Coagulopathy was not significantly associated with post-HT graft complications (odds ratio [OR]: 1.20; 95% CI: 0.95-1.52; P = 0.131) but was associated with increased blood transfusions (OR: 1.92; 95% CI, 1.54-2.41; P < 0.001). Coagulopathy and no-coagulopathy groups had no difference in median length of stay (22 days in each group, P = 0.746), but median total hospital charges were higher among patients with coagulopathy compared to those without (US$425 643 vs US$389 656; P = 0.008). Conclusions: In this national study of HT recipients, pretransplant coagulopathy was common, increased over time, and was not significantly associated with post-HT graft complications or increased hospital stay. However, it was associated with increased bleeding risk, in-hospital mortality, and total hospital charges. These findings may have implications for the selection of patients for HT.

Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015

“… 5 Cardiac conditions occurring from 2009 until the date the antibiotic was dispensed were evaluated and defined consistent with previous investigators. 8 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39…”

Heart transplantation and in‐hospital outcomes in adult congenital heart disease patients with Fontan: A decade nationwide analysis from 2004 to 2014

“…The score ranges from 0 to 33, with higher scores corresponding to greater comorbidity burden. Furthermore, given that coagulopathy is a characteristic comorbid condition in Fontan patients, the definition of coagulopathy included the following ICD‐9‐CM discharge diagnosis: 286.0 to 9, 287.1, 287.3, 287.5, 289.81 to 82; similar methodology has been used before in adult HT recipients …”

“…286.0 to 9, 287.1, 287.3, 287.5, 289.81 to 82; similar methodology has been used before in adult HT recipients. 4…”

Intracerebral Hemorrhage Outcomes in Patients with Systemic Cancer

“…(17) Coagulopathy, a known modifier of outcomes in ICH, was identified using ICD-9-CM diagnosis codes 286.5–286.9, 287.1, 287.3–287.5 and 289.82. (18)…”